You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Colorcon
Dow
Johnson and Johnson
Moodys
Baxter
Express Scripts

Last Updated: August 12, 2020

DrugPatentWatch Database Preview

FREAMINE III 8.5% W/ ELECTROLYTES Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Freamine Iii 8.5% W/ Electrolytes, and what generic alternatives are available?

Freamine Iii 8.5% W/ Electrolytes is a drug marketed by B Braun and is included in one NDA.

The generic ingredient in FREAMINE III 8.5% W/ ELECTROLYTES is amino acids; magnesium acetate; phosphoric acid; potassium acetate; potassium chloride; sodium acetate. There are three hundred and fifty drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the amino acids; magnesium acetate; phosphoric acid; potassium acetate; potassium chloride; sodium acetate profile page.

Summary for FREAMINE III 8.5% W/ ELECTROLYTES
Drug patent expirations by year for FREAMINE III 8.5% W/ ELECTROLYTES
Pharmacology for FREAMINE III 8.5% W/ ELECTROLYTES
Drug ClassAmino Acid

US Patents and Regulatory Information for FREAMINE III 8.5% W/ ELECTROLYTES

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun FREAMINE III 8.5% W/ ELECTROLYTES amino acids; magnesium acetate; phosphoric acid; potassium acetate; potassium chloride; sodium acetate INJECTABLE;INJECTION 016822-007 Jul 1, 1988 RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
AstraZeneca
Baxter
Johnson and Johnson
Mallinckrodt
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.